TITLE

Asthma: mechanisms of inflammation

PUB. DATE
December 2003
SOURCE
Thorax;Dec2003 Supplement 3, Vol. 58, piii15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Vascular endothelial growth factor is highly expressed in the airways of asthmatic patients, and correlates with increased mipcosal vascularity. Current techniques of measuring airway inflammation in asthma such as induced sputom and single flow nitric oxide concentration are limited to sanjpling of the proximal airways. The development of a two compartment !odel of pulmonary nitric oxide production has allowed a non invasive estimation of alveolar nifric oxide concentration. Mast cells inliltrate the bronchial epithelium in asthma placing them at the portal of entry of noxious stimuli. Human lung mast cells adhere avidly to bronchial epithelial monolayers in vitro.
ACCESSION #
12965173

 

Related Articles

  • TIMP-1 in asthma: guilty by association. Johnson, S. R. // Thorax;Aug2005, Vol. 60 Issue 8, p617 

    Focuses on the role of matrix metalloproteinases (MMP) in asthma. Release and activation of growth and angiogenic factors including trasforming growth factor and vascular endothelial growth factor; Contribution of MMPs to altered matrix turnover, epithelial repair and angiogenesis; Association...

  • VEGF obstructs the lungs. Rothenberg, Marc E. // Nature Medicine;Oct2004, Vol. 10 Issue 10, p1041 

    Reports on the role of vascular endothelial growth factor (VEGF), known as a mediator of blood vessel formation and permeability, in allergic lung responses. Cooperation of VEGF with T helper cells in the development of allergic lung responses, at least in an experimental model of asthma in...

  • Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD. Ricciardolo, Fabio L. M.; Sabatini, Federica; Sorbello, Valentina; Benedetto, Sabrina; Defilippi, Ilaria; Petecchia, Loredana; Usai, Cesare; Gnemmi, Isabella; Balbi, Bruno; De Rose, Virginia; ten Hacken, Nick H. T.; Postma, Dirkje S.; Timens, Wim; Stefano, Antonino Di // Thorax;Sep2013, Vol. 68 Issue 9, p803 

    Background: Vascular remodelling plays a central role in asthma and chronic obstructive pulmonary disease (COPD). Bradykinin (BK) is a vasoactive proinflammatory peptide mediating acute responses in asthma. We investigated the role of angiogenic factors in relation to BK receptors in asthma and...

  • Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Kranenburg, A. R.; de Boer, W. I.; Alagappan, V. K. T.; Sterk, P. J.; Sharma, H. S. // Thorax;Feb2005, Vol. 60 Issue 2, p106 

    Background: Ongoing inflammatory, processes resulting in airway and vascular remodelling characterise chronic obstructive pulmonary disease (COPD). Vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 (Fit-1) and VEGFR-2 (KDR/FIk-1) could play a rote in tissue remodelling and...

  • Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe? Papaioannou, Andriana I.; Kostikas, Konstantinos; Kollia, Panagoula; Gourgoulianis, Konstantinos I. // Respiratory Research;2006, Vol. 7, p1 

    Vascular endothelial growth factor (VEGF) is a potent mediator of angiogenesis which has multiple effects in lung development and physiology. VEGF is expressed in several parts of the lung and the pleura while it has been shown that changes in its expression play a significant role in the...

  • Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD. Chetta, Alfredo; Olivieri, Dario // International Journal of Endocrinology;2012, p1 

    In chronic obstructive airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), changes in bronchial microvasculature are present in response to inflammatory stimuli. Vascular changes may significantly contribute to airway wall remodelling. Angiogenesis and vascular...

  • Bronchial hyperreactivity in patients with allergic rhinitis: Forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor. Ciprandi, Giorgio; Tosca, Maria Angela; Signori, Alessio; Cirillo, Ignazio // Allergy & Asthma Proceedings;Mar/Apr2011, Vol. 32 Issue 2, p4 

    Allergic rhinitis (AR) is considered a strong risk factor for the onset of asthma. Bronchial hyperreactivity (BHR) may be present in patients with AR. Forced expiratory flow between 25 and 75% of vital capacity (FEF25-75) may be impaired in AR patients. The aim of this study was to evaluate the...

  • Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we? Thomas, Mike; Pavord, Ian // Primary Care Respiratory Journal;Mar2012, Vol. 21 Issue 1, p8 

    The author reflects on a study related to primary care which examined patients who have mild-to-moderate asthma. He notes that the study indicated that the change in bronchial hyperresponsiveness (BHR) was not different between the examined groups despite that fact that the Single Inhaler...

  • Chapter 9: Asthma classification. Koterba, Alan P.; Saltoun, Carol A. // Allergy & Asthma Proceedings;May/Jun2012 Supplement, Vol. 33, p28 

    Asthma is a chronic inflammatory disorder of the airways resulting physiologically in hyperreactivity and clinically in recurrent episodes of wheezing, chest tightness, or coughing. Airway inflammation, smooth muscle contraction, epithelial sloughing, mucous hypersecretion, bronchial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics